Antipsychotics in Wolff-Parkinson-White Syndrome

Wolff-Parkinson-White Syndrome (WPW) is a rare ventricular pre-excitation syndrome due to the presence of an atrioventricular accessory pathway. WPW patients are prone to fatal arrhythmias. Antipsychotics are FDA-approved for various psychiatric illnesses which increases the possibility of patients with WPW receiving such medications. Currently, there is scarce evidence on the safety of antipsychotics in WPW patients.
Source: Biological Psychiatry - Category: Psychiatry Authors: Tags: Research Method: Pharmacology Source Type: research